Drawing for TIGREZON

USPTO serial 85919928

TIGREZON

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
VOHRA, SANJEEV KUMAR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TIGREZON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M. TEPPER, III TEPPER & EYSTER, PLLC3724 BENSON DRRALEIGH, NC 27609-7321UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 9, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 9, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 21, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 19, 2016EX5GSOU EXTENSION 5 GRANTED—
May 31, 2016EXT5SOU EXTENSION 5 FILED—
May 31, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 19, 2016EX4GSOU EXTENSION 4 GRANTED—
Dec 2, 2015EXT4SOU EXTENSION 4 FILED—
Dec 2, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 5, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 4, 2015EX3GSOU EXTENSION 3 GRANTED—
May 25, 2015EXT3SOU EXTENSION 3 FILED—
May 25, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 17, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 16, 2015EX2GSOU EXTENSION 2 GRANTED—
Jan 15, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 29, 2014EXT2SOU EXTENSION 2 FILED—
Nov 29, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2014EX1GSOU EXTENSION 1 GRANTED—
May 29, 2014EXT1SOU EXTENSION 1 FILED—
May 29, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 8, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 8, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 3, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 29, 2013ALIEASSIGNED TO LIE—
Aug 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Aug 20, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 20, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 20, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 19, 2013DOCKASSIGNED TO EXAMINER—
May 8, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance